Society for Translational Oncology


Highlights from STO's educational activities, including content associated with the Society and its journal The Oncologist. RSS Feed URL

Society for Translational Oncology navigateright Episode

Clonal Hematopoiesis

Clonal hematopoiesis of indeterminate potential (CHIP) is a common, age-associated condition in individuals who do not have a hematologic malignancy or altered blood counts.  Consistent with the concept that CHIP is a pre-malignant state, CHIP is associated with a striking increased risk of hematologic malignancy.  In addition, individuals with CHIP have increased overall mortality and an increased risk of cardiovascular disease.

Benjamin Ebert, MD, PhD 

Dana-Farber Cancer Institute

STO gratefully acknowledges educational grants in partial support of this activity from:
Agios Pharmaceuticals
Celgene Corporation
Novartis Pharmaceuticals Corp.
Pfizer Inc.